[Home ] [Archive]   [ فارسی ]  
:: Main :: About :: Current Issue :: Archive :: Search :: Contact ::
Main Menu
Journal Information::
Articles archive::
For Authors::
For Reviewers::
Contact us::
Site Facilities::
Search in website

Advanced Search
Receive site information
Enter your Email in the following box to receive the site news and information.
Last site contents
:: Editorial Board
:: About Iranian Journal of Endocrinology and Metabolism
:: Volume 20, Issue 5 (2-2019) ::
2019, 20(5): 273-286 Back to browse issues page
Age at Menopause in Women with Polycystic Ovary Syndrome: A Systematic Review
Mina Amiri , Samira Behboudi Gandevani , Sonia Minooee , Fahimeh Ramezani Tehrani
Reproductive Endocrinology Research Center, Research institute for Endocrine Sciences, Shahid Beheshti University of Medical Sciences
Abstract:   (7490 Views)

Introduction: Age of menopause is affected by several factors. While several studies have been conducted on various aspects of polycystic ovary syndrome (PCOS), limited publications have assessed the age at menopause and its related factors in PCOS patients. In this review, we aimed to summarize data of articles available, assessing the age at menopause in women with polycystic ovary syndrome (PCOS). Material and Methods: PubMed (including Medline), Scopus, and Google Scholar, Web of science, and EMBASE databases (up to 2018) were searched to identify published articles, investigating the actual menopausal age and those predicted by the Anti-Mullerian hormone (AMH) in PCOS patients. The quality of studies included was determined using the Newcastle-Ottawa Scale. Results: Current data of studies available demonstrate that the serum concentration of Anti-Mullerian hormone (AMH), as a reliable diagnostic marker to predict ovarian reserve and age at menopause, is significantly higher in patients with PCOS than healthy women. The results of this review show that, in most studies included, the age of menopause, or its estimation based on the serum AMH level, was significantly higher in patients with PCOS, compared with female controls. Conclusion: Delayed menopausal age can be considered window of hope for PCOS women, suffering from infertility, to retrieve their fertility at in later ages.

Keywords: Menopause, Polycystic ovary syndrome, Anti-Mullerian hormone, Ovarian reserve
Full-Text [PDF 439 kb]   (1260 Downloads)    
Type of Study: Review | Subject: Endocrinology
Received: 2018/09/3 | Accepted: 2018/12/15 | Published: 2019/02/15
Add your comments about this article
Your username or Email:


XML   Persian Abstract   Print

Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Amiri M, Behboudi Gandevani S, Minooee S, Ramezani Tehrani F. Age at Menopause in Women with Polycystic Ovary Syndrome: A Systematic Review. Iranian Journal of Endocrinology and Metabolism 2019; 20 (5) :273-286
URL: http://ijem.sbmu.ac.ir/article-1-2460-en.html

Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Volume 20, Issue 5 (2-2019) Back to browse issues page
مجله ی غدد درون‌ریز و متابولیسم ایران، دو ماهنامه  پژوهشی مرکز تحقیقات غدد درون‌ریز و متابولیسم، Iranian Journal of Endocrinology and Metabolism
Persian site map - English site map - Created in 0.05 seconds with 38 queries by YEKTAWEB 4652